ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.


Hierarchy:	Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Acids, Heterocyclic ∟ Nicotinic Acids ∟ Niceritrol 11 coordinate concepts ∟ 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester \| ∟ Arecoline \| ∟ Clonixin \| ∟ Etazolate \| ∟ Niacin \| ∟ Niacinamide \| ∟ Niflumic Acid \| ∟ Nimodipine \| ∟ Pipemidic Acid \| ∟ Piromidic Acid \| ∟ Xanthinol Niacinate Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Heterocyclic Compounds, 1-Ring ∟ Pyridines ∟ Nicotinic Acids ∟ Niceritrol 11 coordinate concepts ∟ 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester \| ∟ Arecoline \| ∟ Clonixin \| ∟ Etazolate \| ∟ Niacin \| ∟ Niacinamide \| ∟ Niflumic Acid \| ∟ Nimodipine \| ∟ Pipemidic Acid \| ∟ Piromidic Acid \| ∟ Xanthinol Niacinate X
Broader terms:	Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Acids, Heterocyclic ∟ Nicotinic Acids ∟ Niceritrol Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Heterocyclic Compounds, 1-Ring ∟ Pyridines ∟ Nicotinic Acids ∟ Niceritrol Nicotinic Acids > Acids, Heterocyclic > Heterocyclic Compounds > Medical Subject Headings (MeSH) Nicotinic Acids > Pyridines > Heterocyclic Compounds, 1-Ring > Heterocyclic Compounds > Medical Subject Headings (MeSH) X
History note:	Nicotinic Acids (1971-1976) \| Propanediols (1971-1976)X
historyNote*:	91(77); was see under NICOTINIC ACIDS 1977-90 X
publicMeSHNote*:	91; was see under NICOTINIC ACIDS 1977-90 X
Scope note:	An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions. X
activeMeSHYear*:	2001 \| 2002 \| 2003 \| 2004 \| 2005 \| 2006 \| 2007X
dateCreated*:	1976-04-13X
dateEstablished*:	1991-01-01X
dateRevised*:	2000-06-22X
recordAuthorizer*:	sjnX
recordMaintainer*:	TWDX
recordOriginator*:	RLSX
Type:	Concept X
Coordinate terms:	3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester \| Arecoline \| Clonixin \| Etazolate \| Niacin \| Niacinamide \| Niflumic Acid \| Nimodipine \| Pipemidic Acid \| Piromidic Acid \| Xanthinol Niacinate X
URI:	X
Labels and equivalent concepts:	Niseritroli (fi) Pentaerythritoltetranicotinate (en, replaced) Pentaerythritol Tetranicotinate (en, replaced) X
Share:	X